Insider trades

Bunnage Mark E.

Bunnage Mark E. made 0 buys and 1 sale on the open market in the last 12 months at Vertex Pharmaceuticals Incorporated. Each trade with the role, price and filing.

Insider trades

Where they report

CompanyRoleHolding afterLatest trade
Vertex Pharmaceuticals Incorporated
NASDAQ:VRTX
EVP, Chief Scientific Officer7,284May 15, 2026

Open-market trades, newest first

CompanyDateTradeSharesPriceValueHolding afterFiled
Vertex Pharmaceuticals Incorporated
NASDAQ:VRTX
May 15, 2026Sale33US$453.45US$14,9647,284May 19, 2026